Early ezetimibe initiation after myocardial infarction significantly lowers cardiovascular events compared to delayed or no combination lipid-lowering therapy.

Patients suffering from myocardial infarction who receive early add-on lipid-lowering medication have a significantly better prognosis than those who ...

People with a certain heart valve abnormality are at increased risk of severe heart rhythm disorders, even after successful valve surgery. This is according to a new study, "Mitral annular disjunction ...

Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not all, new research suggests.

Patients suffering from myocardial infarction who receive early add-on lipid-lowering medication have a significantly better ...

The two low-cost drugs that could prevent a heart attack - One researcher said the combination treatment ‘could help to ...

Giving patients a combination of drugs earlier in their treatment could prevent thousands of heart attacks, according to a new study. Patients should be treated earlier with statins and the ...

Cardiovascular disease is by far the most common cause of death worldwide, and myocardial infarction is the most common acute event.

Cardiovascular disease is by far the most common cause of death worldwide, and myocardial infarction is the most common acute ...

A major new study shows that giving heart attack patients a cholesterol-lowering combo treatment early on – not months later – can dramatically improve their outlook and even save lives. Patients trea ...

HUMACAO, PR AND NEW YORK, NY / ACCESS Newswire / April 14, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the ...

The Philippine Health Insurance Corporation (PhilHealth) has paid the Philippine General Hospital (PGH) PHP22.8 million for ...